Small Molecule Inhibition of the Na(+)/H(+) Exchange Regulatory Factor 1 and Parathyroid Hormone 1 Receptor Interaction
Overview
Affiliations
We have identified a series of small molecules that bind to the canonical peptide binding groove of the PDZ1 domain of NHERF1 and effectively compete with the association of the C-terminus of the parathyroid hormone 1 receptor (PTH1R). Employing nuclear magnetic resonance and molecular modeling, we characterize the mode of binding that involves the GYGF loop important for the association of the C-terminus of PTH1R. We demonstrate that the common core of the small molecules binds to the PDZ1 domain of NHERF1 and displaces a (15)N-labeled peptide corresponding to the C-terminus of PTH1R. The small size (molecular weight of 192) of this core scaffold makes it an excellent candidate for further elaboration in the development of an inhibitor for this important protein-protein interaction.
Drug Design and Synthesis of First in Class PDZ1 Targeting NHERF1 Inhibitors as Anticancer Agents.
Coluccia A, La Regina G, Naccarato V, Nalli M, Orlando V, Biagioni S ACS Med Chem Lett. 2019; 10(4):499-503.
PMID: 30996786 PMC: 6466550. DOI: 10.1021/acsmedchemlett.8b00532.
Saponaro C, Sergio S, Coluccia A, De Luca M, La Regina G, Mologni L Oncogene. 2018; 37(24):3301-3316.
PMID: 29551770 PMC: 6002344. DOI: 10.1038/s41388-018-0170-y.
Cysteine modifiers suggest an allosteric inhibitory site on the CAL PDZ domain.
Zhao Y, Cushing P, Smithson D, Pellegrini M, Pletnev A, Al-Ayyoubi S Biosci Rep. 2018; 38(4).
PMID: 29472314 PMC: 6435542. DOI: 10.1042/BSR20180231.
NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
Georgescu M, Gagea M, Cote G Neoplasia. 2016; 18(8):512-23.
PMID: 27566107 PMC: 5018097. DOI: 10.1016/j.neo.2016.07.003.
NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu M, Mobley B, Orr B, Shang P, Lehman N, Zhu X Acta Neuropathol Commun. 2016; 4(1):55.
PMID: 27229317 PMC: 4882843. DOI: 10.1186/s40478-016-0329-0.